Invitae to Present at Upcoming Investor Conference
Invitae (NYSE: NVTA), a leader in medical genetics, will participate in the Morgan Stanley 20th Annual Global Healthcare Conference on September 13, 2022, at 8:00 a.m. ET in New York City. The event features a fireside chat where management will discuss the company's initiatives. Investors can access a live audio webcast on the company's website, with a replay available afterward. Invitae aims to make genetic testing mainstream, offering improved quality and lower prices for healthcare worldwide. Visit invitae.com for more information.
- None.
- None.
SAN FRANCISCO, Aug. 30, 2022 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced that members of its management team will participate in the following investor conference:
- Morgan Stanley 20th Annual Global Healthcare Conference – Fireside chat on Tuesday, September 13, 2022, at 8:00 a.m. Eastern Time in New York City, New York.
A live audio webcast of the fireside chat may be accessed by visiting the investors section of the company website at ir.invitae.com. A replay of the webcast will be available shortly after the conclusion of the presentation.
About Invitae
Invitae Corporation (NYSE: NVTA) is a leading medical genetics company whose mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people. Invitae's goal is to aggregate the world's genetic tests into a single service with higher quality, faster turnaround time, and lower prices. For more information, visit the company's website at invitae.com.
Contact for Invitae:
Hoki Luk
ir@invitae.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/invitae-to-present-at-upcoming-investor-conference-301614963.html
SOURCE Invitae Corporation
FAQ
When is Invitae's presentation at the Morgan Stanley Global Healthcare Conference?
Where is the Morgan Stanley Global Healthcare Conference taking place?
How can I listen to Invitae's presentation at the conference?
What is the primary focus of Invitae as a company?